Rebecca A Campo1, Karyn L Leniek2, Nicole Gaylord-Scott2, Keturah R Faurot2, Sunyata Smith3, Gary Asher4, Deborah Porterfield5, Susan A Gaylord2. 1. Program on Integrative Medicine, Department of Physical Medicine and Rehabilitation, School of Medicine, CB# 7200, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. rebecca_campo@med.unc.edu. 2. Program on Integrative Medicine, Department of Physical Medicine and Rehabilitation, School of Medicine, CB# 7200, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. 3. School of Education, Lehman College, The City University of New York, Bronx, NY, 10468, USA. 4. Department of Family Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. 5. Preventive Medicine Residency Program, Department of Family Medicine, CB#7595, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Abstract
PURPOSE: Mind-body therapies (MBTs), a subset of complementary and alternative medicine (CAM), are used by cancer survivors to manage symptoms related to their cancer experience. MBT use may differ by cancer survivorship stage (i.e., acute, short-term, long-term) because each stage presents varying intensities of medical activities, associated emotions, and treatment effects. We examined the relationship between MBT use and survivorship stage (acute <1 year; short-term 1 to 5 years; long-term >5 years since diagnosis) using the CAM supplement of the 2012 National Health Interview Survey. We also examined reported reasons for and outcomes of MBT use and frequency of MBT types. METHODS: The sample included cancer survivors (N = 3076) and non-cancer controls (N = 31,387). Logistic regression tested the relationship of MBT use and survivorship stage. Weighted percentages were calculated by survivorship stage for reported reasons and outcomes of use and frequency of MBT types. RESULTS: MBT use varied by cancer survivorship stage (p = 0.02): acute (8.3 %), short-term (15.4 %), long-term (11.7 %) survivorship and non-cancer controls (13.2 %). In the adjusted model, short-term survivors had 35 % greater odds of MBT use than did controls (95 % CI 1.00, 1.83). Reasons for and outcomes of MBT use varied among the survivorship stages, with more acute survivors reporting medical-related reasons and more short-term survivors reporting to manage symptoms. CONCLUSIONS: MBT may fulfill different symptom management needs at varying stages of survivorship. These findings can help inform supportive care services of survivors' use of MBT for symptom burden at each stage and the allocation of these services.
PURPOSE: Mind-body therapies (MBTs), a subset of complementary and alternative medicine (CAM), are used by cancer survivors to manage symptoms related to their cancer experience. MBT use may differ by cancer survivorship stage (i.e., acute, short-term, long-term) because each stage presents varying intensities of medical activities, associated emotions, and treatment effects. We examined the relationship between MBT use and survivorship stage (acute <1 year; short-term 1 to 5 years; long-term >5 years since diagnosis) using the CAM supplement of the 2012 National Health Interview Survey. We also examined reported reasons for and outcomes of MBT use and frequency of MBT types. METHODS: The sample included cancer survivors (N = 3076) and non-cancer controls (N = 31,387). Logistic regression tested the relationship of MBT use and survivorship stage. Weighted percentages were calculated by survivorship stage for reported reasons and outcomes of use and frequency of MBT types. RESULTS: MBT use varied by cancer survivorship stage (p = 0.02): acute (8.3 %), short-term (15.4 %), long-term (11.7 %) survivorship and non-cancer controls (13.2 %). In the adjusted model, short-term survivors had 35 % greater odds of MBT use than did controls (95 % CI 1.00, 1.83). Reasons for and outcomes of MBT use varied among the survivorship stages, with more acute survivors reporting medical-related reasons and more short-term survivors reporting to manage symptoms. CONCLUSIONS: MBT may fulfill different symptom management needs at varying stages of survivorship. These findings can help inform supportive care services of survivors' use of MBT for symptom burden at each stage and the allocation of these services.
Entities:
Keywords:
Cancer survivors; Cancer survivorship stage; Integrative health; Mind Body Therapy; National Health Interview Survey
Authors: Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam Journal: J Cancer Surviv Date: 2010-10-06 Impact factor: 4.442
Authors: Virginia P Henderson; Lynn Clemow; Ann O Massion; Thomas G Hurley; Susan Druker; James R Hébert Journal: Breast Cancer Res Treat Date: 2011-09-08 Impact factor: 4.872
Authors: Wendy A Weiger; Michael Smith; Heather Boon; Mary Ann Richardson; Ted J Kaptchuk; David M Eisenberg Journal: Ann Intern Med Date: 2002-12-03 Impact factor: 25.391
Authors: Caitlin Mason; Catherine M Alfano; Ashley Wilder Smith; Ching-Yun Wang; Marian L Neuhouser; Catherine Duggan; Leslie Bernstein; Kathy B Baumgartner; Richard N Baumgartner; Rachel Ballard-Barbash; Anne McTiernan Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04-10 Impact factor: 4.254
Authors: Agnete E Kristoffersen; Fuschia M Sirois; Trine Stub; Anne Helen Hansen Journal: BMC Complement Altern Med Date: 2017-06-19 Impact factor: 3.659
Authors: Lou Ann Scarton; Guilherme Del Fiol; Ingrid Oakley-Girvan; Bryan Gibson; Robert Logan; T Elizabeth Workman Journal: J Med Libr Assoc Date: 2018-01-02